The mutation rate and cancer.

The mutation rate and cancer.

The selection of advantageous mutations underlies tumorigenesis. The growth of a tumor is therefore a form of evolution at the somatic level, in which the population is comprised of individual cells within the tumor. Models of tumorigenesis have considered the relative importance of mutation and sel...

Bibliografske podrobnosti
Main Authors:	Tomlinson, I, Novelli, MR, Bodmer, W
Format:	Journal article
Jezik:	English
Izdano:	1996

Podobne knjige/članki

Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog.
od: Tomlinson, I, et al.
Izdano: (1999)

How many mutations in a cancer?
od: Tomlinson, I, et al.
Izdano: (2002)

Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability.
od: Ilyas, M, et al.
Izdano: (1996)

Mutations, evolutionary theory and cancer.
od: Tomlinson, I
Izdano: (1993)

SDH mutations in cancer.
od: Bardella, C, et al.
Izdano: (2011)

SDH mutations in cancer
od: Bardella, C, et al.
Izdano: (2011)

Beta-catenin mutations in cell lines established from human colorectal cancers.
od: Ilyas, M, et al.
Izdano: (1997)

The low frequency of beta-catenin mutations in cell lines established from human colorectal cancers
od: Ilyas, M, et al.
Izdano: (1997)

Replicative DNA polymerase mutations in cancer.
od: Heitzer, E, et al.
Izdano: (2014)

Replicative DNA polymerase mutations in cancer
od: Heitzer, E, et al.
Izdano: (2014)

Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
od: Beck, N, et al.
Izdano: (1997)

Tissue, cell and stage specificity of (epi)mutations in cancers.
od: Sieber, O, et al.
Izdano: (2005)

Molecular genetics of colon cancer.
od: Tomlinson, I, et al.
Izdano: (1997)

Rare genetic variants and the risk of cancer.
od: Bodmer, W, et al.
Izdano: (2010)

The in vivo rate of somatic adenomatous polyposis coli mutation.
od: Hornsby, C, et al.
Izdano: (2008)

The effects of mutational processes and selection on driver mutations across cancer types
od: Temko, D, et al.
Izdano: (2018)

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
od: Liu, Y, et al.
Izdano: (2006)

Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.
od: Halford, SE, et al.
Izdano: (2003)

DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load.
od: Tomlinson, I, et al.
Izdano: (1997)

Using somatic APC mutations as clonal markers to demonstrate polyclonality in colonic polyps
od: Leedham, S, et al.
Izdano: (2007)

Mutational changes that lead to the loss of expression of HLA-A* in colorectal cancer
od: Bicknell, D, et al.
Izdano: (2002)

"Null" HLA A*0101 mutation identified in a colorectal cancer cell line
od: Bicknell, D, et al.
Izdano: (2001)

Genomic and cDNA sequence analysis of the cell matrix adhesion regulator gene.
od: Durbin, H, et al.
Izdano: (1997)

Mutations in Bcl10 are very rare in colorectal cancer.
od: Stone, J, et al.
Izdano: (1999)

Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia.
od: Leedham, S, et al.
Izdano: (2009)

Defining the clinical phenotype of hereditary nonpolyposis colorectal cancer
od: Beck, N, et al.
Izdano: (1999)

Mutations in the AXIN1 gene in advanced prostate cancer.
od: Yardy, G, et al.
Izdano: (2009)

Tumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimeras.
od: Novelli, MR, et al.
Izdano: (1999)

E-cadherin mutations in human colorectal cancer cell lines
od: Wheeler, J, et al.
Izdano: (1999)

E-cadherin mutations in human colorectal cancer cell lines
od: Wheeler, J, et al.
Izdano: (1999)

Estimation of mutation rates.
od: Gravenor, M, et al.
Izdano: (2004)

APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
od: Rowan, A, et al.
Izdano: (2000)

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
od: Woodford-Richens, K, et al.
Izdano: (2001)

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway
od: Woodford-Richens, K, et al.
Izdano: (2001)

Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q.
od: Frayling, I, et al.
Izdano: (1997)

Genetic pathways in colorectal and other cancers.
od: Ilyas, M, et al.
Izdano: (1999)

Genetic pathways in colorectal and other cancers.
od: Ilyas, M, et al.
Izdano: (1999)

A panoply of errors: polymerase proofreading domain mutations in cancer
od: Rayner, E, et al.
Izdano: (2016)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers.
od: Woodford-Richens, K, et al.
Izdano: (2001)

Molecular testing for somatic mutations in common cancers: the views of UK oncologists.
od: Wordsworth, S, et al.
Izdano: (2008)